Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
23 Jul 2021	Submitted	Original manuscript
26 Jul 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
26 Jul 2021	Editorially accepted
6 Sep 2021	Article published	10.1186/s13063-021-05487-z

Back to article page